Advances in Erythrocytes Membrane Research

A special issue of Membranes (ISSN 2077-0375). This special issue belongs to the section "Biological Membrane Functions".

Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 337

Special Issue Editors


E-Mail Website
Guest Editor
Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal
Interests: cardiovascular risk factors; anemia of chronic kidney disease; obesity; inflammation
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
LAQV, REQUIMTE, Laboratório de Química Aplicada, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
Interests: erythrocyte membrane; oxidative stress; hereditary spherocytosis; hemodialysis; biomaterials biocompatibility

Special Issue Information

Dear Colleagues,

The red blood cell (RBC) has long been one of the most studied type of cells. Research on its membrane was the foundation for the spectrin-based membrane skeleton model and for the understanding of the model’s structure and function. In recent years, scientific and technological advancements have led to a renewal in erythrocyte membrane investigation, ranging from basic research to clinical hematology, expanding the knowledge on RBC membrane physiology and biomedical innovations. For instance, next-generation sequencing methodologies hold potential as new diagnostics tools for erythrocyte membrane diseases, which are rare and heterogeneous disorders with a wide-range of clinical presentations. Their accurate diagnosis, with identification of the underlying genetic defect in each individual case, is important to establish prognosis and personalized clinical management. Furthermore, an increasing interest in RBCs is emerging with the possibility of using them as drug/molecule carriers/delivery systems, based on their inherent biocompatibility and lifespan. Modifying erythrocyte membranes by coating them with nanoparticles, imaging, or therapeutic agents has unlocked new insights into diagnosis, drug delivery, and targeted immunotherapy, namely for cancer treatment. The aim of this Special Issue is to gather a collection of comprehensive studies focusing on state-of-the-art erythrocyte membrane research pertinent to diagnosis and therapeutic applications.

Prof. Dr. Alice Santos-Silva
Dr. Susana Rocha
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Membranes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • erythrocyte membrane
  • red blood cell membrane disorders
  • clinical diagnosis and treatment
  • next-generation sequencing technology
  • molecular mechanisms of disease
  • biomedical applications
  • nanomaterials
  • drug delivery systems
  • targeted immunotherapy

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop